Human Heredity
Original Paper
Novel Nucleotide Substitutions within the Coding Region of DNMT2 Are in Strong Linkage Disequilibrium in Caucasians and JapaneseFranchina M. · Kay P.H.Department of Pathology, The University of Western Australia, Perth, Australia
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Published online: November 12, 2001
Issue release date: November 2001
Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 1
ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)
For additional information: https://www.karger.com/HHE
Abstract
Investigations into mechanims by which cytosine methylation may be genetically controlled have led to the identification of single nucleotide polymorphisms within the coding region of DNMT2 that are conserved in different ethnic groups. The DNMT2 I allele includes a G at nucleotide position 104 of exon 2 and a C at position 50 of exon 4. The alternative allele, DNMT2 II, includes an A and T, respectively, at these positions. G was never found in the absence of C and vice versa and A was never found in the absence of T and vice versa. The gene products of DNMT2 I and DNMT2 II differ by the inclusion of a histidine or tyrosine residue at the position specified by codon 101. This amino acid substitution alters the amino acid composition of a conserved methylating enzyme motif shown to be involved in S-adenosylmethionine binding in M.HhaI, a bacterial methyltransferase that is almost identical to DNMT2 in size and structure. Demonstration of strong linkage disequilibrium between the nucleotide substitutions associated with each DNMT2 allele provides valuable tools for the investigation of molecular genetic mechanisms of evolution and speciation.
© 2001 S. Karger AG, Basel
Related Articles:
References
- Klimasauskas S, Kumar S, Roberts RJ, Cheng X: HhaI methyltransferase flips its target base out of the DNA helix. Cell 1994;76:357–369.
- Kumar S, Cheng X, Klimasauskas S, Mi S, Posfai J, Roberts RJ, Wilson GG: The DNA (cytosine-5) methyltransferases. Nucleic Acids Res 1994;22:1–10.
- Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986;321:209–213.
- Holliday R, Pugh JE: DNA modification mechanisms and gene activity during development. Science 1975;187:226–232.
- Naveh-Many T, Cedar H: Active gene sequences are undermethylated. Proc Natl Acad Sci USA 1981;78:4246–4250.
-
Li E, Beard C, Jaenisch R: Role for DNA methylation in genomic imprinting. Nature 1993;366:451–456.
- Kanduri C, Raman R: Characterisation of developmentally regulated chromatin structure in the coding region of the proto-oncogene, c-fos, in the male laboratory mouse. Int J Dev Biol 1999;43:279–282.
- Simon D, Stuhlmann H, Jahner D, Wagner H, Werner E, Jaenisch R: Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious. Nature 1983;304:275–277.
- Doerfler W, Schubbert R, Heller H, Kammer C, Hilger-Eversheim K, Knoblauch M, Remus R: Integration of foreign DNA and its consequences in mammalian systems. Trends Biotechnol 1997;15:297–301.
-
Oberle I, Rousseau F, Heitz D, Kretz C, Devys D, Hanauer A, Boue J, Bertheas MF, Mandel JL: Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 1991;285:1097–1102.
- Xu GL, Bestor TH, Dourc’his D, Hsieh CL, Tommerup N, Bugge M, Hulten M, Qu X, Russo JJ, Viegas-Pequignot E: Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999;402:187–190.
- MacLeod AR, Szyf M: Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J Biol Chem 1995;270:8037–8043.
- Franchina M, Kay PH: Evidence that cytosine residues within 5′-CCTGG-3′ pentanucleotides can be methylated in human DNA independently of the methylating system that modifies 5′-CG-3′ dinucleotides. DNA Cell Biol 2000;19:521–526.
- Okano M, Xie S, Li E: Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998;19:219–220.
- Yoder JA, Bestor TH: A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast. Hum Mol Genet 1998;7:279–284.
- Okano M, Xie S, Li E: Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res 1998;26:2536–2540.
- Pinarbasi E, Elliot J, Hornby DP: Activation of a yeast pseudo DNA methyltransferase by deletion of a single amino acid. J Mol Biol 1996;257:804–813.
- Van den Wyngaert I, Sprengel J, Kass SU, Luyten WHML: Cloning and analysis of a novel human putative DNA methyltransferase. FEBS Lett 1998;426:283–289.
- Klimasauskas S, Nelson JL, Roberts RJ: The sequence specificity domain of cytosine-C5 methylases. Nucleic Acids Res 1991;19:6183–6190.
- Pradhan S, Roberts RJ: Hybrid mouse-prokaryotic DNA (cytosine-5) methyltransferases retain the specificity of the parental C-terminal domain. EMBO J 2000;19:2103–2114.
- Posfai J, Bhagwat AS, Posfai G, Roberts RJ: Predictive motifs derived from cytosine methyltransferases. Nucleic Acids Res 1989;17:2421–2435.
- Wu JC, Santi DV: Kinetic and catalytic mechanism of HhaI methyltransferase. J Biol Chem 1987;262:4778–4786.
-
Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1982.
- Dong A, Yoder JA, Zhang X, Zhou L, Bestor TH, Cheng X: Structure of human DNMT2, an enigmatic DNA methyltransferase homolog that displays denaturant-resistant binding to DNA. Nucleic Acids Res 2001;29:439–448.
- Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB, Sidransky D: 5′-CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995;1:686–692.
- Robertson KD, Manns A, Swinnen LJ, Zong JC, Gulley ML, Ambinder RF: CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt’s lymphoma and Hodgkin’s disease. Blood 1996;88:3129–3136.
- Taylor JME, Kay PH, Spagnolo DV: The diagnostic significance of Myf-3 hypermethylation in malignant lymphoproliferative disorders. Leukemia 2001;15:583–589.
- Tishkoff SA, Dietzsch E, Speed W, Pakstis AJ, Kidd JR, Cheung K, Bonne-Tamir B, Santachiara-Benerecetti AS, Moral P, Krings M, Paabo S, Watson E, Risch N, Jenkins T, Kidd KK: Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science 1996;271:1380–1387.
- Tishkoff SA, Goldman A, Galafell F, Speed WC, Deinard AS, Bonne-Tamir B, Kidd JR, Pakstis AJ, Jenkins T, Kidd KK: A global haplotype analysis of the myotonic dystrophy locus: Implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations. Am J Hum Genet 1998;62:1389–1402.
- Baird DM, Coleman J, Rosser ZH, Royle NJ: High levels of sequence polymorphism and linkage disequilibrium at the telomere of 12q: Implications for telomere biology and human evolution. Am J Hum Genet 2000;66:235–250.
- Payseur BA, Nachman MW: Microsatellite variation and recombination rate in the human genome. Genetics 2000;156:1285–1298.
Article / Publication Details
Published online: November 12, 2001
Issue release date: November 2001
Number of Print Pages: 7
Number of Figures: 4
Number of Tables: 1
ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)
For additional information: https://www.karger.com/HHE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
